Tirzepatide is used in weekly injectable medications for the treatment of type 2 diabetes and weight management. 

If approved, a healthcare provider on the Qyral platform will prescribe a compounded medication containing tirzepatide, which may also include additional metabolic support ingredients. The pharmacy that will ship to you depends on your state of residence, and each pharmacy that Qyral partners with has its own unique set of metabolic support ingredients, and your licensed healthcare provider may prescribe varying components to your compounded medication. Therefore, depending on the state and the individualized assessment performed by your healthcare provider, you may receive different metabolic support ingredients from the corresponding pharmacy.